Dyne Therapeutics Inc (DYN) is trading up at $18.15 (+4.49%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.
Dyne submits biologics license application for DMD treatment
Dyne submits biologics license application for DMD treatment
TECO acquires 78% stake in Malaysia’s Dynaciate for $50.8m
TECO acquires 78% stake in Malaysia’s Dynaciate for $50.8m
Goldman says pay attention to this important shift in FX market dynamics
Goldman says pay attention to this important shift in FX market dynamics